Abstract:Objective To investigate the application value of susceptibility weighted imaging (SWI) combined with platelet distribution width (PDW) in intravenous thrombolysis for treatment of patients with acute cerebral infarction (ACI). Methods One hundred and ten patients with ACI treated by intravenous thrombolysis admitted to the Department of Radiology of the Second Affiliated Hospital of Medical College of Zhejiang University from February 2017 to June 2018 were enrolled as the subjects. Before treatment, all patients were detected by routine magnetic resonance imaging (MRI), SWI scanning and PDW detection. The patients were divided into hemorrhage group (77 cases) and non-hemorrhage group (33 cases) according to the presence or absence of hemorrhage shown in SWI, and according to the amount of bleeding, the hemorrhage group patients were subdivided into light (24 cases), medium (32 cases) and severe (21 cases) three groups. After intravenous thrombolysis, the patients were scanned by SWI to show whether bleeding being present or not, the cerebral microbleeding (CMBs) after 24 hours treatment in two groups, and after treatment of 14 days, modified Rankin score (MRS), PDW and hemorrhagic transformation (HT) situation in the two groups were evaluated and compared, the differences in hemorrhagic infarction 1 (HI1), hemorrhagic infarction 2 (HI2), parenchymal hemorrhage 1 (PH1) and parenchymal hemorrhage 2 (PH2) in different bleeding volume groups were compared. Results Before treatment, 129 lesions detected by SWI were significantly greater than 14 lesions detected by T1 weighted imaging, 22 lesions detected by T2 weighted imaging and 86 lesions detected by diffusion weighted imaging. After treatment for 24 hours, the number of CMBs (number: 10 vs. 0), after treatment for 14 days, the incidence of HT [36.36% (28/77) vs. 12.12% (4/33)], MRS (1.78±0.39 vs. 1.51±0.42) and PDW [(12.34±5.29)% vs. (6.79±3.27)%] in the hemorrhagic group were higher than those in non-hemorrhagic group (all P < 0.05). After treatment of 14 days, the incidences of HT [71.43% (15/21) vs. 20.83% (5/24), 25.00% (8/32)], PDW [(14.52±4.11)% vs. (10.78±3.67)%, (11.34±3.89)%] in severe group were higher than those in light group and moderate groups (all P < 0.05), and the rate of good prognosis was significantly lower than those in mild and moderate groups [42.86% (9/21) vs. 70.83% (17/24), 71.88% (23/32), P < 0.05]. The incidence of HT in severe group was also significantly higher than those in the non-hemorrhage group [71.43% (15/21) vs. 11.76% (4/34), P < 0.05]. Conclusion SWI combined with PDW can guide the intravenous thrombolysis very well for patients with ACI, and has relatively high clinical value.

Effect of injection duration on bruising associated with subcutaneous low molecular weight heparin

Effects of human-computer interaction intelligent compression package for heparin injection in patients with orthopedic surgery

Influence of Low‐molecular‐weight Heparin Injection Sites on Local Bruising and Pain: A Systematic Review and Meta‐analysis

Effect of Cold Application on Pain and Bruising in Patients With Subcutaneous Injection of Low-Molecular-Weight Heparin: A Meta-Analysis

Assessment of four different methods in subcutaneous heparin applications with regard to causing bruise and pain.

A study on application value of susceptibility weighted imaging combined with platelet distribution width in intravenous thrombolysis for treatment of patients with acute cerebral infarction

Effect of cold application and compression on pain and bruising in subcutaneous heparin injection

Injection Techniques to Reduce Adverse Effects of Subcutaneous Low‐Molecular‐Weight Heparin Among Patients With Cardiovascular Diseases: A Scoping Review

Cold Application on Bruising at the Subcutaneous Heparin Injection Site: A Systematic Review and Meta-Analysis

Effect of bivalirudin injection on fibrinogen and thrombin time of healthy Chinese subjects

[Effect of different acupuncture needle-retaining time on hemorheology in ischemic stroke patients]

Inverse Relationship of Bleeding Risk with Clot Burden During Pulmonary Embolism Treatment with LMW Heparin.

Efficacy and Safety Study on Low Molecular Heparin in the Prevention for Venous Thromboembolism Prophylaxis after Spontaneous Intracerebral Hemorrhage

Effect of bydroxyethyl starch with different degrees of substitution on expression of platelet membrane glycoprotein

Effects of Heparin and Domestic Bivalirudin on Coagulation During Percutaneous Coronary Intervention

Effect of Micro-heparin Flushes on Blood Coagulation During The Continuous Arterial Blood Pressure Monitoring

To Compare the Curative Effect of the Antiplatelet Therapy Between Puerarin Injection and Xueshuantong Injection Among Patients with Unstable Angina After Percutaneous Coronary Stent Implantation

Effect of Shuxuetong Injection on Coagulation Function

Safety of Early Nadroparin for Prevention Deep Vein Thrombosis in Patients with Intracerebral Hemorrhage

Effect of Different Initial Anticoagulant Strategies on Short‐term Outcome of Patients with Symptomatic DVT in China

Clinical Efficacy of Xueshuantong Injection Combined with Rivaroxaban in the Prevention of Deep Venous Thrombosis after Operation of Lower Limb Fracture and Its Influence on Hemorheology